PEN Q3 2025 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q3 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$355M+17.8% YoY

Gross Profit

$240M67.8% margin

Operating Income

$49M13.8% margin

Net Income

$46M12.9% margin

EPS (Diluted)

$1.17

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$58M

Free Cash Flow

$42M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$386M

Stockholders' Equity

$1.4B

Cash & Equivalents

$321M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$355M	$301M	+17.8%
Gross Profit	$240M	$200M	+20.0%
Operating Income	$49M	$35M	+38.1%
Net Income	$46M	$30M	+55.3%

Geographic Segments

UNITED STATES

$275M78%

Other Non-US

$80M22%